{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:03:29Z","timestamp":1719187409227},"reference-count":58,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2217\/fon.15.1","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T09:37:11Z","timestamp":1431423431000},"page":"1543-1553","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Advancing Radioimmunotherapy and Its Future Role in Non-Hodgkin Lymphoma"],"prefix":"10.1080","volume":"11","author":[{"given":"Patrick M","family":"Reagan","sequence":"first","affiliation":[{"name":"Wilmot Cancer Institute, \rUniversity of Rochester Medical Center, \r601 Elmwood Avenue, \rBox 704, \rRochester, \rNY14642, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W","family":"Friedberg","sequence":"additional","affiliation":[{"name":"Wilmot Cancer Institute, \rUniversity of Rochester Medical Center, \r601 Elmwood Avenue, \rBox 704, \rRochester, \rNY14642, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"issue":"4","key":"e_1_3_2_3_1","first-page":"513","article-title":"131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma: a Phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital","volume":"18","author":"Turner JH","year":"2003","unstructured":"Turner JH , MartindaleAA, BoucekJ, ClaringboldPG, LeahyMF. 131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma: a Phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital. Cancer Biother. Radiopharm.18(4), 513\u2013524 (2003).","journal-title":"Cancer Biother. Radiopharm."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.2923.2923"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk155"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.06.056"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.062"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291702"},{"issue":"3","key":"e_1_3_2_9_1","first-page":"457","article-title":"Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma","volume":"2","author":"Knox SJ","year":"1996","unstructured":"Knox SJ , GorisML, TrislerKet al. Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin. Cancer Res.2(3), 457\u2013470 (1996).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290703"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3793"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1316"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.19.3918"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.076"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.3470"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3883"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2004.n.015"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22617"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500376076"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.9217"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.0892"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn172"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7863"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-068056"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2758-y"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041511"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.1553"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12695"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.949260"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3110"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.803"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70039-1"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr633"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr145"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.6400"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.8198"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.8325"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.4101"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.369.369"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2444"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm560"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12906"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.2245"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9248"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.2922"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.1215"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.093450"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08991.x"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9453"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270538"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324392"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-417808"},{"key":"e_1_3_2_53_1","first-page":"114","article-title":"Tositumomab and iodine I-131 tositumomab for previously untreated, advanced-stage, follicular lymphoma: median 10 year follow-up results","author":"Kaminski MS","year":"2009","unstructured":"Kaminski MS , TuckM, EstesJet al. Tositumomab and iodine I-131 tositumomab for previously untreated, advanced-stage, follicular lymphoma: median 10 year follow-up results. Blood, 114 (2009).","journal-title":"Blood"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2882"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7906"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3429"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1169"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.2835"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.15.1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:21Z","timestamp":1719125121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.15.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.2217\/fon.15.1"],"URL":"https:\/\/doi.org\/10.2217\/fon.15.1","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}